Skip to main content

Table 3 Association between CIP2A expression in patients with acute myeloid leukemia and the response to induction therapy and the relapse rate

From: Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients

 High CIP2A (n = 21)
Distribution [n (%)]
Low CIP2A (n = 39)
Distribution [n (%)]
P valueRelative risk (95% CI)
Response to induction therapy0.571.2 (0.6–2.54)
 Complete remission13 (61.9)27 (69.2)  
 Resistance8 (38.1)12 (30.8)  
Relapse0.270.4 (0.11–1.99)
 Still in complete remission19 (90.5)31 (79.8)  
 Relapsed2 (9.5)8 (20.2)